Cervical cancer in developing countries - Publications of the team members

Publications and presentations of the team members

Cervical cancer in developing countries

Publications of the team members

Negulescu R-A, Catarino R, De Vuyst H, Undurraga-Malinverno M, Meyer-Hamme U, Alec M, Campana A, Vassilakos P, Petignat P. Web-based instrument to assess skills in visual inspection of the cervix among healthcare providers. Int J Gynaecol Obstet. 2016 Jul;134(1):107-13. http://dx.doi.org/10.1016/j.ijgo.2015.11.024
Catarino R, Vassilakos P, Jinoro J, Broquet C, Benski A-C, Meyer-Hamme U, Petignat P. Human papillomavirus prevalence and type-specific distribution of high- and low-risk genotypes among Malagasy women living in urban and rural areas. Cancer Epidemiol. 2016 Jun;42:159-66. http://dx.doi.org/10.1016/j.canep.2016.04.013
Catarino RR, Vassilakos PP, Royannez-Drevard II, Guillot CC, Alzuphar SS, Fehlmann AA, Meyer-Hamme UU, Petignat PP. Barriers to Cervical Cancer Screening in Geneva (DEPIST Study). J Low Genit Tract Dis. 2016 Apr;20(2):135-8. http://dx.doi.org/10.1097/LGT.0000000000000173
Gallay C, Miranda E, Schaefer S, Catarino R, Jacot-Guillarmod M, Menoud P-A, Guerry F, Achtari C, Sahli R, Vassilakos P, Petignat P. Human papillomavirus (HPV) contamination of gynaecological equipment. Sex Transm Infect. 2016 Feb;92(1):19-23. http://dx.doi.org/10.1136/sextrans-2014-051977
Catarino R, Vassilakos P, Tebeu P-M, Schäfer S, Bongoe A, Petignat P. Risk factors associated with human papillomavirus prevalence and cervical neoplasia among Cameroonian women. Cancer Epidemiol. 2016 Feb;40:60-6. http://dx.doi.org/10.1016/j.canep.2015.11.008
Vassilakos P, Catarino R, Bougel S, Munoz M, Benski C, Meyer-Hamme U, Jinoro J, Heriniainasolo JL, Petignat P. Use of swabs for dry collection of self-samples to detect human papillomavirus among Malagasy women. Infect Agents Cancer. 2016;11:13. http://dx.doi.org/10.1186/s13027-016-0059-8
Catarino R, Petignat P, Dongui G, Vassilakos P. Cervical cancer screening in developing countries at a crossroad: Emerging technologies and policy choices. World J Clin Oncol. 2015 Dec 10;6(6):281-90. http://dx.doi.org/10.5306/wjco.v6.i6.281
Ricard-Gauthier D, Wisniak A, Catarino R, van Rossum AF, Meyer-Hamme U, Negulescu R, Scaringella S, Jinoro J, Vassilakos P, Petignat P. Use of Smartphones as Adjuvant Tools for Cervical Cancer Screening in Low-Resource Settings. J Low Genit Tract Dis. 2015 Oct;19(4):295-300. http://dx.doi.org/10.1097/LGT.0000000000000136
Pirek D, Petignat P, Vassilakos P, Gourmaud J, Pache J-C, Rubbia-Brandt L, Sando Z, McKee TA, Ho L. Human papillomavirus genotype distribution among Cameroonian women with invasive cervical cancer: a retrospective study. Sex Transm Infect. 2015 Sep;91(6):440-4. http://dx.doi.org/10.1136/sextrans-2014-051642
Broquet C, Triboullier D, Untiet S, Schafer S, Petignat P, Vassilakos P. Acceptability of self-collected vaginal samples for HPV testing in an urban and rural population of Madagascar. Afr Health Sci. 2015 Sep;15(3):755-61. http://dx.doi.org/10.4314/ahs.v15i3.8
Fokom-Domgue J, Combescure C, Fokom-Defo V, Tebeu PM, Vassilakos P, Kengne AP, Petignat P. Performance of alternative strategies for primary cervical cancer screening in sub-Saharan Africa: systematic review and meta-analysis of diagnostic test accuracy studies. BMJ. 2015 Jul 3;351:h3084.
Bigoni J, Gundar M, Tebeu P-M, Bongoe A, Schäfer S, Fokom-Domgue J, Catarino R, Tincho EF, Bougel S, Vassilakos P, Petignat P. Cervical cancer screening in sub-Saharan Africa: a randomized trial of VIA versus cytology for triage of HPV-positive women. Int J Cancer. 2015 Jul 1;137(1):127-34. http://dx.doi.org/10.1002/ijc.29353
Tebeu P-M, Fokom-Domgue J, Crofts V, Flahaut E, Catarino R, Untiet S, Vassilakos P, Petignat P. Effectiveness of a two-stage strategy with HPV testing followed by visual inspection with acetic acid for cervical cancer screening in a low-income setting. Int J Cancer. 2015 Mar 15;136(6):E743–50. http://dx.doi.org/10.1002/ijc.29250.
Bigoni J, Gundar M, Tebeu P-M, Bongoe A, Schäfer S, Fokom-Domgue J, Catarino R, Tincho EF, Bougel S, Vassilakos P, Petignat P. Cervical cancer screening in sub-Saharan Africa: A randomized trial of VIA versus cytology for triage of HPV-positive women. Int J Cancer. 2014 Nov 24. http://dx.doi.org/10.1002/ijc.29353.
Untiet S, Vassilakos P, McCarey C, Tebeu P-M, Kengne-Fosso G, Menoud P-A, Boulvain M, Navarria I, Petignat P. HPV self-sampling as primary screening test in sub-Saharan Africa: implication for a triaging strategy. Int J Cancer. 2014 Oct 15;135(8):1911–7. http://dx.doi.org/10.1002/ijc.28834.
Fokom-Domgue J, Vassilakos P, Petignat P. Is screen-and-treat approach suited for screening and management of precancerous cervical lesions in Sub-Saharan Africa? Prev Med. 2014 Aug;65:138–40. http://dx.doi.org/10.1016/j.ypmed.2014.05.014.
Sossauer G, Zbinden M, Tebeu P-M, Fosso GK, Untiet S, Vassilakos P, Petignat P. Impact of an educational intervention on women's knowledge and acceptability of human papillomavirus self-sampling: a randomized controlled trial in Cameroon. PLoS ONE. 2014;9(10):e109788. http://dx.doi.org/10.1371/journal.pone.0109788.
Berner A, Hassel SB, Tebeu P-M, Untiet S, Kengne-Fosso G, Navarria I, Boulvain M, Vassilakos P, Petignat P. Human papillomavirus self-sampling in Cameroon: women's uncertainties over the reliability of the method are barriers to acceptance. J Low Genit Tract Dis. 2013 Jul;17(3):235–41. http://dx.doi.org/10.1097/LGT.0b013e31826b7b51.
McCarey C, Pirek D, Tebeu PM, Boulvain M, Doh AS, Petignat P. Awareness of HPV and cervical cancer prevention among Cameroonian healthcare workers. BMC Womens Health. 2011;11:45. http://dx.doi.org/10.1186/1472-6874-11-45.
Tebeu P-M, Petignat P, Mhawech-Fauceglia P. Gynecological malignancies in Maroua, Cameroon. Int J Gynaecol Obstet. 2009 Feb;104(2):148–9. http://dx.doi.org/10.1016/j.ijgo.2008.09.005.